PTPRN and type 1 diabetes mellitus: Moreover, although the absence of the pancreatic anti-GAD and/or IA2 has been shown to discriminate Type 1 diabetes from MODY with a sensitivity of 99% and specificity of 84%, positive pancreatic antibodies have been reported in few patients (< 1%) with MODY [19, 20].